Journals / Solunum Hastalıkları / 2004 / Cilt: 15 - Sayı: 1

A rare etiology of hemoptysis: Antiphospholipid antibody syndrome

Nadir bir hemoptizi nedeni: Antifosfolipid antikor sendromu

Pages
43–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present this case as a rare cause of recurrent hemoptysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thirty-nine years old female presenting with dyspnea and hemoptysis for two years was admitted to the hospital.
📊
Key Findings & Data:Laboratory studies had shown anemia, thrombocytopenia, proteinuria and rise of erythrocyte sedimentation rate.
💡
Conclusion & Impact:We present this case as a rare cause of recurrent hemoptysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antikorlar · antikardiyolipin · Antifosfolipid sendromu

Abstract

Thirty-nine years old female presenting with dyspnea and hemoptysis for two years was admitted to the hospital. She had a history of fetal losses for eight times. Physical examination of the chest was found normal. Ground-glass opacification due to alveolar edema at the basis of the lung were seen on lung computed tomography. Laboratory studies had shown anemia, thrombocytopenia, proteinuria and rise of erythrocyte sedimentation rate. Activated partial thrombop-lastin time and bleeding time were prolonged. The level of anticardiolipin antibodies IgG (aCL-lgG), were high and the lupus anticoagulants (LA) were positive. Mix test was positive for inhibitors. Primary antiphospholipid antibody syndrome was diagnosed with presence of the recurrent fetal losses, thrombocytopenia, positive aCL-lgG and LA, cutaneous, pulmonary and renal manifestations. Oral anticoagulant therapy was started. During treatment she got pregnant, but as hepatic and renal insufficiency delivered the pregnancy was terminated. She died because of multiple organ disfunction. We present this case as a rare cause of recurrent hemoptysis.

Özet

Antifosfolipid antikor sendromu (APLS), venöz ve arteriyel trombüsler, tekrarlayan düşükler, trombositopeni ile seyreden ve birçok sistemi tutabilen bir sendromdur. Otuzdokuz yaşında bayan hasta, iki yıldır süren hemoptizi ve nefes darlığı şikayeti ile başvurdu. Özgeçmişinde sekiz düşük hikayesi vardı. Solunum sistemi muayenesi normaldi. Toraks bilgisayarlı tomografisinde her iki akciğer bazallerinde alveoler ödeme bağlı yamalı tarzda buzlu cam görünümü izlendi. Ekokardiyografide pulmoner arter ortalama basıncı 55 mmHg olarak ölçüldü. Laboratuvar incelemelerinde anemi, trombositopeni, eritrosit sedimentasyon hızında yükseklik ve proteinüri saptandı. Aktive parsiyel tromboplastin zamanı ve kanama zamanı uzamıştı. Antikardiyolipin antikor IgG (aCL-lgG) düzeyi yüksek, lupus antikoagülanı (LA) pozitif bulundu ve miks testi pozitifti.Olguya tekrarlayan düşükler, trombositopeni, aCL-lgG yüksekliği, LA pozitifliği, solunum ve renal sistem tutulumu nedeniyle APLS tanısı konuldu. Oral antikoagülan tedavi başlandı. Gebeliği takiben hastada karaciğer ve böbrek yetmezliği gelişmesi üzerine gebelik sonlandırıldı. Ancak multiorgan yetmezliği gelişen hasta kaybedildi. APLS, tekrarlayan hemoptizilerin ayırıcı tanısında görülen nadir nedenlerden biri olarak sunuldu.

🔖

Cite This Article

MUTLU, L. C., TÜRKER, G., GÜLBAŞ, G., YILDIRIM, Z., AYDOĞDU, İ. (2004). A rare etiology of hemoptysis: Antiphospholipid antibody syndrome. Solunum Hastalıkları, Cilt: 15 - Sayı: 1, 43–46. https://ajindex.com/articles/318539

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Ames PR, Khamastha MA, Hughes GR. Clinical and therapeutic aspects of the antiphospholipid syndrome. Lupus 1995;4(Suppl 1):23-5
  2. Levine JS, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;7:752-63
  3. Daugas E, Nochy D, Huong du LT, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002;13:42-52
  4. Fedullo PF, Auger WR, Channick RN, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 1995;16:353-7
  5. Fedullo PF, Auger WR, Channick RN, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001;3:561-81
  6. Mooser KM, Auger WR, Fedullo PF, et al. Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment. Eur Respir J 1992;5:334-42
  7. Yıldırım N. Kronik tromboembolik pulmoner hipertansiyon klinik ve tanı kriterleri. In: Metintaş M, ed. Pulmoner tromboemboli. 2nd ed. Eskişehir: ASD Toraks Yayınları, 2001;265-73
  8. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753-9
  9. Al Hajjaj MS. Massive pulmonary hemorrhage in a Saudi female with primary antiphospholipid syndrome. Saudi Med J 2000;2:777-9
  10. Watere GW, Latham B, Waring JA, Gabbay E. Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis. Respirology 1999;4:405-8
  11. Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome spectrum of disease and treatment. J Rheumatol 1999;26:805-7
  12. Gertner E, Lie JT. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993;20: 1224-8
  13. Gülbay BE, Karnak D, Kayacan O, Beder S. Primer antifosfolipid sendromu: Olgu sunumu. Tüberküloz ve Toraks Dergisi 2001;49:483-8
  14. Uzun K, Sayarlıoğlu M, Zehir İ ve ark. Antifosfolipid sendromu: Akciğer komplikasyonu ile seyreden iki olgu. Solunum 2002;4:251-4
  15. Cordier FC. Alveolar hemorrhage. In: Grassi C, Brambilla C, Costabel U, Stockley RA, Naeije R, Roisn RR, eds. Pulmonary diseases. Mc Graw-Hill International (UK) Ltd, 1999;253-7
  16. Maes M, Bosmans E, Suy E, et al. Antiphospholipid antinuclear, Epstein Barr and cytomegalovirus antibodies and soluable interleukin-2 receptors in depressive patients. J Affective Disord 1991;21:133-40
  17. Maes M, Mellzer H, Suy E, et al. Autoimmunitiy in